Tech Company Inital Public Offerings
Aquinox Pharmaceuticals IPO
Aquinox Pharmaceuticals was acquired by . Aquinox Pharmaceuticals shares were listed on 3/7/2014.
Transaction Overview
Company Name
Announced On
3/7/2014
Transaction Type
IPO
Amount
$46,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
887 Great Northern Way 450
Vancouver BC, V5T 4T5
Canada
Vancouver BC, V5T 4T5
Canada
Phone
Website
Email Address
Overview
Aquinox is a venture-backed pharmaceutical company and world leader in the discovery and development of novel, first-in-class, small molecules against SHIP1.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Main
Chief Financial Officer
Kamran Alam
Chief Medical Officer
Barbara Troupin
Chief Operating Officer
Abigail Jenkins
VP - Bus. Development
Paul Brennan
VP - Bus. Development
Lloyd Mackenzie
VP - Human Resources
Shelley McCloskey
VP - Operations
David Green
Browse more venture capital transactions:
Prev: 3/7/2014: DataRPM venture capital transaction
Next: 3/7/2014: Blaze Medical Devices venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs